Procter & Gamble topped expectations in fiscal 2025's Q2 with strong revenue figures, but it continues to face challenges with supply chain costs.

Companies like Oracle (ORCL), Microsoft (MSFT) as well as riskier investments in quantum computing and AI are crowding out the interest in slower moving stocks like Procter and Gamble.

Market participants were in full risk-on mode Wednesday as an AI-fueled rally in big tech stocks and a batch of upbeat corporate earnings sent stocks to fresh highs. Tech stocks dominated the list of biggest gainers after President Trump unveiled The Stargate Project,

Procter & Gamble (PG) faces challenges with foreign exchange rates & cyberattack impact ahead of Q2 earnings.

Consumer products behemoth Proctor & Gamble (NYSE:PG) will be announcing earnings results tomorrow before market open. Here’s what to look for. Procter & Gamble missed analysts’ revenue ...

Shares of household products giant Procter & Gamble (NYSE: PG) were gaining today after the maker of Crest toothpaste and Gillette razors posted another solid earnings report, edging out analyst ...

Wells Fargo raised the firm’s price target on Procter & Gamble to $180 from $176 and keeps an Overweight rating on the shares. The bias on

Truist Financial analyst Bill Chappell maintained a Buy rating on Procter & Gamble (PG – Research Report) today. The company’s shares

Image source: Getty Images. P&G keeps growing Procter & Gamble said that organic sales, which strips out the impact of foreign exchange, divestitures, and acquisitions in the fiscal second quarter ...

We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to take a look at where The Procter & Gamble Company (NYSE:PG) stands against other Kevin O’Leary’s stock picks for 2025.

We recently published a list of Jim Cramer Discusses These 13 Stocks & Rejects The AI PC Super Cycle. In this article, we are going to take a look at where The Procter & Gamble Company (NYSE:PG) stands against other stocks that Jim Cramer discusses.

Procter & Gamble Hygiene & Healthcare Ltd. key Products/Revenue Segments include Hygiene Products, Creams & Ointments, Cough Drops, Tablets for the year ending 30-Jun-2024.For the quarter ended 30-09-2024, the company has reported a Standalone Total Income ...